Literature DB >> 6222266

Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues.

R E Wharen, R E Anderson, E R Laws.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6222266     DOI： 10.1227/00006123-198304000-00013

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  9 in total

1.  Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.

Authors:  F M Little; C J Gomer; S Hyman; M L Apuzzo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

2.  Photoradiation therapy of 9L-gliosarcoma in rats: hematoporphyrin derivative (types I and II) followed by laser energy.

Authors:  M K Cheng; J McKean; B Mielke; J Tulip; D Boisvert
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

3.  Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.

Authors:  J S Hill; S B Kahl; A H Kaye; S S Stylli; M S Koo; M F Gonzales; N J Vardaxis; C I Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

4.  Penetration of hematoporphyrin derivative into rat brain and intracerebral 9L glioma tissue.

Authors:  D P Boisvert; J D McKean; J Tulip; J Cummins; M K Cheng
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

5.  Photosensitization of human glioma cells by chalcogenapyrylium dyes.

Authors:  S K Powers; D L Walstad; J T Brown; M Detty; P J Watkins
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

6.  Photodynamic therapy is potentiated by Co60 and intratumoral injection of hematoporphyrin derivative.

Authors:  H Kostron; M R Swartz; R L Martuza
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130

7.  Selective necrosis of malignant gliomas in mice using photodynamic therapy.

Authors:  D R Sandeman; R Bradford; P Buxton; S G Bown; D G Thomas
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

8.  Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.

Authors:  J C Bremner; G E Adams; J K Pearson; J M Sansom; I J Stratford; J Bedwell; S G Bown; A J MacRobert; D Phillips
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

9.  Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action.

Authors:  M C Berenbaum; G W Hall; A D Hoyes
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.